PharmaCrunch

Mergers & Acquisitions in Pharma World 2010-11


Top Deals in Pharma M & A

Rank
Target company
Target Country
Acquiror Company
Acquiror Country
Value (in billion Euro)
Status
1
Genzyme Corporation
United States
Sanofi-Aventis SA
France
14.6
Pending
2
Alcon Inc
Switzerland
Novartis AG
Switzerland
9.1
Pending
3
Millipore Corp.
United States
Merck KGaA
Germany
4.5
Completed
4
Gilead Sciences Inc
U.S.
Gilead
U S
4.0
Intended
5
Ratiopharm Inter.
Germany
Teva Pharm
Israel
3.6
Completed
6
Novo Nordisk A/S
Denmark
Novo Nordisk
Denmark
3.4
Intended
7
Valeant Pharm
U. S.
Bioavail Corp
Canada
3.0
Completed
8
Talecris
U.S.
Grifols SA
Spain
3.0
Pending
9
OSI Pharmacueticals
U.S.
Ruby Inc
U.S.
3.0
Completed
10
Piramal Healthcare Ltd
India
Abbott Labs
U.S.
3.0
Completed

0 responses on "Mergers & Acquisitions in Pharma World 2010-11"

Leave a Message

Your email address will not be published. Required fields are marked *

FREE PHARMA NEWSLETTER VIA EMAIL

Join fastest growing subscribers who benefit from PharmaCrunch’s coverage on "Pharmaceuticals - Must to Know" updates

Testimonial from Subscribers

Read more

Pradeep Agarwal

Marketing - AstraZeneca
top
2016 © PharmaCrunch All rights reserved
Skip to toolbar